
Nasal Spray Shows Promise in Reducing COVID-19 and Cold Risks
A recent study suggests that nasal sprays, particularly those containing the antihistamine azelastine, may significantly reduce the risk of contracting COVID-19 and the common cold by blocking viruses at the entry point in the nose, though larger studies are needed to confirm these findings.

